Marshall Wace’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
1,207,871
+123,831
| +11% | +$1.73M | 0.02% | 585 |
|
|
2025
Q1 | $14.6M | Buy |
+1,084,040
| New | +$14.6M | 0.02% | 569 |
|
|
2024
Q4 | – | Sell |
-684,799
| Closed | -$15.6M | – | 2836 |
|
|
2024
Q3 | $15.6M | Buy |
684,799
+611,825
| +838% | +$13.9M | 0.02% | 538 |
|
|
2024
Q2 | $949K | Sell |
72,974
-5,727
| -7% | -$74.5K | ﹤0.01% | 1556 |
|
|
2024
Q1 | $1.38M | Sell |
78,701
-222,588
| -74% | -$3.9M | ﹤0.01% | 1326 |
|
|
2023
Q4 | $6.56M | Sell |
301,289
-661,204
| -69% | -$14.4M | 0.01% | 683 |
|
|
2023
Q3 | $14.8M | Buy |
962,493
+311,314
| +48% | +$4.78M | 0.03% | 475 |
|
|
2023
Q2 | $15.5M | Buy |
651,179
+21,859
| +3% | +$520K | 0.03% | 502 |
|
|
2023
Q1 | $16M | Buy |
629,320
+17,863
| +3% | +$454K | 0.03% | 467 |
|
|
2022
Q4 | $17.9M | Buy |
611,457
+2,795
| +0.5% | +$81.6K | 0.04% | 436 |
|
|
2022
Q3 | $12.5M | Buy |
608,662
+163,863
| +37% | +$3.36M | 0.03% | 642 |
|
|
2022
Q2 | $5.15M | Buy |
444,799
+427,236
| +2,433% | +$4.94M | 0.01% | 1177 |
|
|
2022
Q1 | $326K | Sell |
17,563
-70,842
| -80% | -$1.31M | ﹤0.01% | 2246 |
|
|
2021
Q4 | $1.75M | Buy |
+88,405
| New | +$1.75M | ﹤0.01% | 1669 |
|